Tonix Pharmaceuticals to Present at the MIXiii Biomed Conference in Israel
May 20, 2014 08:40 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, May 20, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced that its CEO, Seth Lederman, MD, will be speaking at MIXiii Biomed, an Israel Innovation...
Tonix Pharmaceuticals Reports First Quarter 2014 Financial Results
May 13, 2014 17:00 ET
|
Tonix Pharmaceuticals Holding Corp.
- Three Programs to be in Clinical Development in 2014 -
- Cash of $49.5 Million as of March 31, 2014 -
NEW YORK, May 13, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp....
Tonix Pharmaceuticals Completes Enrollment in BESTFIT Trial of TNX-102 SL for Fibromyalgia
May 12, 2014 08:40 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, May 12, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a clinical-stage pharmaceutical company, today announced that it has completed enrollment in the BESTFIT...
Tonix Pharmaceuticals Spotlighted in April 7 Issue of BioCentury
April 09, 2014 08:40 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, April 9, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage pharmaceutical company, was spotlighted in the April 7, 2014 issue of BioCentury: The...
Tonix Pharmaceuticals Appoints Donald J. Kellerman Senior Vice President, Clinical Development and Regulatory Affairs
April 01, 2014 08:45 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, April 1, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced the appointment of Donald J. Kellerman, Pharm.D. to the position of Senior Vice President,...
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results
March 31, 2014 09:15 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, March 31, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced financial results for the fourth quarter and full year ended December 31, 2013.
"In the...
Tonix Pharmaceuticals to Present at the ROTH Conference
March 05, 2014 08:20 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, March 5, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, will be presenting at the 26th Annual ROTH...
Tonix Pharmaceuticals Completes Pre-IND Meeting With FDA on TNX-201 for Episodic Tension-Type Headache: Clinical Development to Begin in 4Q 2014
March 03, 2014 09:35 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, March 3, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, today announced that it recently held a...
Tonix Pharmaceuticals Spotlighted in Three Media Outlets in February
February 21, 2014 08:20 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Feb. 21, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, has been featured in TheStreet.com, Genetic...
Tonix Pharmaceuticals to Present at the BIO CEO Conference
February 04, 2014 08:40 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, will be presenting at the 16th Annual BIO CEO &...